Why is Poly Medicure Ltd falling/rising?

Recent Price Performance and Market Context

Poly Medicure’s share price has been on a downward trajectory, losing 5.74% over the past week and 12.92% in the last month, significantly underperforming the Sensex, which declined by only 0.99% and 1.20% respectively during these periods. The year-to-date performance is particularly stark, with the stock plunging 34.80% while the Sensex has gained 8.36%. Over the last year, the stock has delivered a negative return of 37.36%, in contrast to the Sensex’s positive 8.21% gain. Despite this recent weakness, the company’s longer-term performance remains robust, with a three-year return of 89.31% and a five-year return exceeding 230%, well above the benchmark’s respective gains.

On 30-Dec, the stock hit an intraday low of ₹1,693.85, setting a fresh 52-week low. The weighted average price indicates that more volume was traded near this low, signalling selling pressure. Poly Medicure is trading below all key moving averages—5-day, 20-day, 50-day, 100-day, and 200-day—highlighting a bearish technical setup. The stock has also underperformed its sector, Medical Equipment/Supplies/Accessories, which itself declined by 2.11% on the day.

Fundamental Challenges and Valuation Concerns

Despite its sizeable market capitalisation of ₹17,638 crore, making it the second largest company in its sector and accounting for 15.60% of the sector’s market cap, Poly Medicure faces fundamental headwinds. The company reported flat financial results in September 2025, with a notably low dividend payout ratio of 10.70%, which may disappoint income-focused investors. Additionally, the debtors turnover ratio stands at a low 4.02 times, indicating slower collection efficiency compared to peers.

Valuation metrics further weigh on investor sentiment. The company’s return on equity (ROE) is 12.4%, but it trades at a high price-to-book value of 5.9, suggesting expensive valuation levels. While the stock’s price-to-earnings growth (PEG) ratio of 2.1 reflects moderate growth expectations, the market appears cautious given the stock’s significant underperformance relative to the broader market and its peers. Over the past year, profits have risen by 22.8%, yet the stock price has declined sharply, signalling a disconnect that may be attributed to concerns over sustainability of earnings growth or broader market sentiment.

Investor participation has also diminished, with delivery volumes on 29 Dec falling by 28.6% compared to the five-day average, indicating reduced buying interest. This decline in investor engagement, combined with the stock’s technical weakness and sectoral pressures, has contributed to the ongoing downtrend.

Sector and Institutional Context

Poly Medicure benefits from a low average debt-to-equity ratio of zero, reflecting a conservative capital structure. Institutional investors hold a significant 23.31% stake, which typically suggests confidence in the company’s fundamentals. However, even with strong institutional backing, the stock’s recent performance indicates that broader market and sector dynamics are weighing heavily. The medical equipment sector’s decline on the day and the stock’s underperformance relative to its peers suggest that investors are cautious amid uncertain near-term prospects.

In summary, Poly Medicure’s share price decline on 30-Dec is driven by a combination of disappointing recent financial results, expensive valuation metrics, technical weakness, and subdued investor participation. While the company’s long-term growth story remains intact, the current market environment and fundamental challenges have led to sustained selling pressure, resulting in the stock hitting new lows and underperforming both its sector and the broader market.

Get 2 full years of MojoOne Premium for only Rs. 12,999. Subscribe for 1 year and we'll add another year FREE. Offer valid for a limited time. Start Saving Now →